The E2 factor (E2F) family of transcription factors are downstream targets of the retinoblastoma protein. E2F factors have been known for several years to be important regulators of S-phase entry. Recent studies have improved our understanding of the molecular mechanisms of action used by this transcriptional network. In addition, they have given us an appreciation of the fact that E2F has functions that reach beyond G1/S control and impact cell proliferation in several different ways. The discovery of new family members with unusual properties, the unexpected phenotypes of mutant animals, a diverse collection of biological activities, a large number of new putative target genes and the new modes of transcriptional regulation have all contributed to an increasingly complex view of E2F function. In this review, we will discuss these recent developments and describe how they are beginning to shape a new and revised picture of the E2F transcriptional program.
Introduction
The E2 factor (E2F) family of transcription factors are downstream effectors of the retinoblastoma (RB) protein pathway and are believed to play a pivotal role in cell division control.
Since its discovery, E2F has been viewed as a positive regulator of genes required for DNA synthesis. More recent studies have shown that this view needs to be greatly expanded. As the activities attributed to E2F have become more diverse, E2F has been found to play contrasting roles in different contexts. E2F functions as both an activator and repressor of transcription. It acts in cell proliferation and differentiation, as a regulator of cell death, and in both tumor suppression and oncogenesis. The application of new technologies such as DNA microarray analysis, chromatin immunoprecipitation (ChIP) techniques and bioinformatics has enlarged the view of the number and nature of genes potentially regulated by E2F. These range in function from the traditional set of G1/S regulators to genes with other cell cycle functions, DNA repair and recombination, apoptosis, differentiation and development, as well as genes of unknown function (reviewed in DeGregori, 2002; Cam and Dynlacht, 2003) .
For a comprehensive coverage of the E2F field, the reader is referred to several excellent reviews (Dyson, 1998; Helin, 1998; Nevins, 1998; DeGregori, 2002; Trimarchi and Lees, 2002) . In this review, we will present the recent findings that have contributed to the increasingly complex picture of the E2F transcriptional network. Specifically, we will concentrate on five major topics: the recent expansion of the E2F family through the addition of new members; the variety of biological activities that have been associated with E2F; the mechanisms of action of E2Fs; and the functional integration of the different modules of the E2F/RB network. Finally, we will discuss E2F function in the context of tumor formation.
The extended family of E2F transcription factors
Since the initial identification of the cellular factor required for the activation of the E2 viral promoter, the E2 factor (E2F), (reviewed in Dyson, 1998; Nevins, 1998) , the E2F family of transcription factors has been growing steadily through the addition of new members in mammals and through the discovery of homologs in other eukaryotes. This expansion has led to an appreciation of the differences between E2F members. Individual E2Fs have distinct mechanisms of action, and regulation, and are associated with particular types of biological activities.
The evolutionary conservation of the E2F/RB pathway E2F and RB homologs have been described in flies (Dynlacht et al., 1994; Ohtani and Nevins, 1994; Hao et al., 1995; Du et al., 1996a; Sawado et al., 1998; , worms (Ceol and Horvitz, 2001; Page et al., 2001) , frogs (Suzuki and Hemmati-Brivanlou, 2000) and in several different plant species (Ramirez-Parra et al., 1999; Sekine et al., 1999; Albani et al., 2000; Magyar et al., 2000; Rossignol et al., 2002) . The importance of the E2F/RB pathway is underlined by its evolutionary conservation, and this conservation has paved the way for studies in several different model organisms.
The E2F/RB pathway is more streamlined in flies and worms than the complex picture found in mammalian cells (see below and Figure 1 ). This simplicity has greatly aided the analysis of E2F function. Drosophila possesses only two E2F genes (dE2F1 and dE2F2), one DP (dDP) and two RB-like genes (RBF1 and RBF2). Caenorhabditis elegans has one RB (LIN-35), one DP (DPL-1) and two E2F (EFL-1 and EFL-2) genes. The roles of these genes, their genetic interactions with other components and the ways that their functions are integrated together have provided valuable insights into the biological significance of E2F proteins and their mechanisms of action. As described in later sections, studies in these organisms provide paradigms for E2F functions that are thus far underappreciated in mammalian cells such as direct roles in DNA replication and functions in early development. a) The E2F/RB network in mammals and other species. The mammalian E2F/RB network is comprised of many different E2F/pocket-protein complexes. Activator E2Fs (E2F1, E2F2 and E2F3) interact only with pRB; there are several different repressor E2Fs: E2F4 can interact with all three pocket proteins, E2F5 binds to p130, E2F6 binds to PcG proteins, and E2F6 and E2F7 do not interact with pocket proteins. The E2F/RB pathway is evolutionary conserved. In Drosophila, the pathway is functionally conserved but contains fewer members, with interaction patterns similar to those in mammals: RBF1 binds both activator and repressor dE2F, and RBF2 binds to repressor dE2F only. C. elegans contains only one pocket protein , one DP (DPL-1) and two E2Fs (EFL-1 and EFL-2). (b) Domain structure of mammalian E2F proteins. E2F1-6 contain one DNA-binding domain (DB) and one DP dimerization domain (DIM). Transactivation domains and sequences for binding to pocket proteins are present only in E2F1-5, and the pocket-protein-binding domain is contained within the transactivation domain. E2F1-3 have a nuclear localization signal (NLS), andE2F4 and E2F5 have nuclear export signals (NES). E2F7 lacks a dimerization domain and contains two DNA-binding domains The E2F family of transcription factors DK Dimova and NJ Dyson The mammalian E2F family In mammals, E2F activity is generated by a large number of interconnected complexes -seven E2F genes (E2F1-7), two DP (DP1 and DP2) genes and three genes encoding RBrelated proteins (RB, p107 and p130) have been identified to date (Figure 1a) . In this review, we will divide E2Fs into two sets of proteins -the traditional and well-studied set of E2Fs (E2F1-5) and the newly discovered, novel set (E2F6, E2F7; E2F3b).
E2F/RB network in mammals
The traditional E2F family members The traditional E2F proteins can be subdivided into two groups based on their transcriptional properties, their cell cycle properties, and their interactions with pRB and the two related proteins, p107 and p130 (the so-called family of 'pocket' proteins) (Figure 1 ). E2F1, E2F2 and E2F3 (E2F3a) are potent transcriptional activators, interact exclusively with pRB and are periodically expressed during the cell cycle. E2F4 and E2F5 are expressed in most cell types. They are poor transcriptional activators and appear to function as repressors by recruiting pocket proteins to E2F-regulated promoters. E2F4 can interact with all three pocket proteins, E2F5 binds p130 (for a review see Sardet et al., 1997; Dyson, 1998; Nevins, 1998) . In general, the activator E2Fs promote cell cycle progression, whereas the repressor E2Fs are believed to be required for cell cycle exit and differentiation. Thus, activator and repressor E2Fs function in opposite ways, and studies in Drosophila have demonstrated that the activator dE2F1 and the repressor dE2F2 antagonize each other in vivo (Frolov et al., 2001) .
The novel E2F family members
The newest additions to the mammalian family all appear to function as transcriptional repressors. E2F3b is encoded by a unique mRNA transcribed from the E2F3 locus (He et al., 2000; Leone et al., 2000) and it differs from the previously characterized E2F3 protein (now termed E2F3a) only in its N-terminus (Figure 1b) . While E2F3a is an activator E2F with cell cycleregulated expression patterns, E2f3b is constitutively expressed similar to E2F4 and E2F5. E2f3b is the predominant E2F/RB complex in some types of quiescent cells and it is believed to function as a transcriptional repressor. Recent findings (see section E2F family member-specific functions) suggest that E2F3b has an unusual role in cycling cells in the constitutive repression of specific E2F target genes (Aslanian et al., 2004; PJ Iaquinta and JA Lees, personal communication) .
E2F6 and E2F7 have features that set them apart from other members of the E2F family. Unlike the previously described E2Fs, E2F6 and E2F7 lack the transactivation and pocket-protein-binding domains ( Figure 1b ) and they repress transcription in a pocketprotein-independent manner. E2F6 has been shown to repress transcription through association with Polycomb group (PcG) proteins (Trimarchi and Lees, 2002;  reviewed in Frolov and Dyson, 2004) , but the repression mechanism used by E2F7 remains to be elucidated. Like other E2Fs, E2F6 functions in conjunction with either DP1 or DP2 (Morkel et al., 1997; Cartwright et al., 1998; Gaubatz et al., 1998; Trimarchi et al., 1998) . In contrast, E2F7 represents an entirely different class of E2F factors that were first discovered in Arabidopsis thaliana (Kosugi and Ohashi, 2002; Mariconti et al., 2002) . These proteins contain two DNA-binding domains and bind to DNA in a DP-independent manner, possibly as a homodimer Di Stefano et al., 2003; Logan et al., 2004) . Both the E2F6 and the E2F7 loci produce several alternatively spliced mRNAs, which encode distinct protein isoforms. There are two E2F7 isoforms (Di Stefano et al., 2003) and two and four isoforms of E2F6 in mouse and human, respectively (Dahme et al., 2002; Kherrouche et al., 2004) . The biological activities of the different isoforms remain to be determined.
The functions of the most recently identified E2F family members are currently under investigation. Overexpression studies demonstrate that E2F6 can repress E2F-responsive genes, and that high levels in quiescent cells can delay re-entry into the cell cycle (Cartwright et al., 1998; Gaubatz et al., 1998; Trimarchi et al., 1998) . Consistent with these observations, an E2F6 containing chromatin-modifying complex was detected at cell cycle-regulated promoters in G0 cells (Ogawa et al., 2002) . However, mouse embryonic fibroblasts (MEFs) isolated from E2F6-deficient mice exhibited no defects in assays of cell proliferation or quiescence (Storre et al., 2002) . Other studies have shown that the promoters of cell cycle genes are occupied by E2F4/p130 complexes in quiescent cells (Takahashi et al., 2000; Wells et al., 2000) and these observations suggest that E2F6 likely acts redundantly with other repressor E2Fs at cell cycle genes. Potentially, E2F6 may act primarily at a different set of targets. Large-scale promoter binding and expression studies have suggested that E2F6 can regulate the expression of a number of genes encoding functions involved in tumor suppression and chromatin structure, including BRCA1 (Oberley et al., 2003) . The association of E2F6 with PcG proteins (Trimarchi et al., 2001; Ogawa et al., 2002) raised the possibility that E2F6 might function in the regulation of Hox genes. PcG proteins are required to maintain the stable repression and to regulate the developmental expression patterns of Hox genes (Gould, 1997; Schumacher and Magnuson, 1997) . Intriguingly, E2f6À/À mice have posterior homeotic transformations of the axial skeleton, which are strikingly similar to those observed in mice deficient in several different PcG proteins (Storre et al., 2002 and references therein) .
Much less is known about E2F7. E2F7 was recently found at a subset of cell cycle-regulated, E2F-dependent promoters and its ectopic expression resulted in the suppression of gene expression (Di Stefano et al., 2003) . Interestingly, E2F7 was found to associate with promoters during S and G2 phases of the cell cycle, suggesting that E2F7 may function to repress E2F targets at a time when other E2F/pocket-protein complexes have been disrupted and are presumably nonfunctional.
Viewed together, these new classes of E2F proteins suggest that mammalian cells contain multiple types of E2F repressor complexes: E2F/DP complexes that repress in association with pRB family members, E2F/ DP repressor complexes that act independent of pRB family members and E2F proteins that repress without a DP or pRB family members.
The biological activities of E2F
The activities of E2F1-5 are modulated by the binding of pocket-proteins, and this relationship has been conserved during evolution. These interactions negatively affect E2F-dependent transcription in two waysbinding to E2Fs inhibits their ability to activate transcription. In addition, when pRB-related proteins are recruited to promoters by repressor E2Fs, they can actively repress transcription by associating with various chromatin-modifying repressive complexes (reviewed in Harbour and Dean, 2000a; Ferreira et al., 2001; Frolov and Dyson, 2004) . E2F activity is also regulated by various additional mechanisms (for a detailed review see Helin, 1998; Muller and Helin, 2000) .
The most intensively studied and best-understood function of E2F is its ability to regulate the G1/S transition and S-phase entry during the cell cycle. This property is at the center of most models for E2F function. However, a variety of additional activities have been ascribed to E2F and RB and, although not all of them are well understood, they paint a picture of the E2F pathway that is far more interesting and complex. Some of these activities are discussed in more detail below.
The traditional view of E2F function: controlling S-phase entry E2F/RB proteins provide a module of transcriptional regulation that couples the expression of many genes required for S-phase entry with cell cycle progression. Repressor E2F/pocket-protein complexes are prevalent in G0 and early G1 phase of the cell cycle and are disrupted in late G1 (Figure 2a ). This is attributed primarily to the phosphorylation of pocket proteins by the G1 Cdks cyclin D/cdk4,6 and cyclin E/cdk2. Late in G1, activator E2Fs turn on the transcription of these genes (reviewed in DeGregori, 2002; Trimarchi and Lees, 2002) .
In agreement with this model, E2F4 and E2F5, which repress expression of S-phase genes, appear to be required for cell cycle exit and differentiation, and cells lacking repressor E2Fs fail to respond to certain cell cycle arrest signals (Mann and Jones, 1996; Gaubatz et al., 2000; Wu et al., 2001) . Conversely, consistent with their ability to induce the expression of S-phase genes, overexpression of activator E2Fs drives quiescent cells into S phase (Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994; Kowalik et al., 1995; Lukas et al., 1996; DeGregori et al., 1997; Vigo et al., 1999) . E2F4 and E2F5 also have this capacity when overexpressed, albeit to a much lesser degree (Lukas et al., 1996; DeGregori et al., 1997) . In Drosophila, the overexpression of dE2F1, the activator E2F, also induces ectopic S-phase entry (Asano et al., 1996; Du et al., 1996b) , and in Arabidopsis, differentiated and nondividing leaf cells can re-enter S phase upon ectopic expression of AtE2F-a and AtDP-a (Rossignol et al., 2002) . The activator E2Fs can also overcome growth arrest signals such as TGFb or Cdk inhibitors (DeGregori et al., 1995b; Schwarz et al., 1995; Mann and Jones, 1996) . Furthermore, the overexpression of E2F1, E2F2 or E2F3a leads to the transformation of primary cells (Johnson et al., 1994; Shan and Lee, 1994; Singh et al., 1994; Xu et al., 1995) . It should be noted that activator E2Fs do not always promote S-phase entry. In some settings, E2F1 can either promote or inhibit DNA replication upon gamma irradiation treatment (DeGregori et al., 1995a; He et al., 2000) . Moreover, overexpression of E2F can induce senescence in human primary fibroblasts (Dimri et al., 2000) and apoptosis in many different cell types (reviewed in DeGregori, 2002; Trimarchi and Lees, 2002) . The ability of E2F to induce S phase depends on the cellular context.
The idea that activator E2Fs are required to regulate cell proliferation is strongly supported by studies in which the endogenous proteins were removed. de2f1 mutant flies have attenuated S phases and are severely growth retarded (Duronio et al., , 1998 Brook et al., 1996; Royzman et al., 1997; Frolov et al., 2001) . Similarly, depletion of dE2F1 by RNA interference (RNAi) in fly cells results in the cessation of DNA replication and G1 arrest Frolov et al., 2003) . Antibody-mediated inhibition of E2F3 causes cell cycle arrest in primary cells , and E2F3-deficient MEFs have reduced rates of proliferation (Humbert et al., 2000b) . Furthermore, the combined inactivation of E2F1, E2F2 and E2F3 is sufficient to block cellular proliferation completely . Studies in Xenopus using a dominantnegative form of E2F also indicate that E2F is required for cell cycle progression (Tanaka et al., 2003) .
E2F controls the expression of genes encoding various DNA replication proteins and cell cycle regulators, and it seems logical that E2F-dependent expression of these genes would be needed to sustain cell proliferation. However, it is not clear whether this is the only activity of E2F that limits S-phase entry. Transcript levels of Sphase genes are significantly reduced in cells lacking activator E2F (Humbert et al., 2000b; Wu et al., 2001; Dimova et al., 2003; Frolov et al., 2003; Angus et al., 2004) , but the protein levels of many DNA replication proteins remained unchanged (Angus et al., 2004) . The significance of this finding is uncertain. While the levels of some proteins involved in DNA synthesis may not be rate limiting for S-phase entry, it is always possible that there are other E2F targets that are; however, the identity of such targets is not known for certain. Good candidates are cyclin E and/or cyclin A, whose levels do fluctuate in the cell cycle and can be rate limiting for S-phase entry (reviewed in Sherr and Roberts, 1999; Vidal and Koff, 2000) . Consistent with this notion, the ectopic expression of cyclin E can transiently rescue DNA replication defects in de2f1 mutant embryos in flies . However, E2F has targets other than cyclin E and the overexpression of E2F1 can drive cells into S phase without a significant rise in cyclin E-associated kinase activity (DeGregori et al., 1995b) . As both cyclin E and cyclin A also regulate E2F activity (reviewed in Helin, 1998; Muller and Helin, 2000) , it is difficult to place them downstream of E2F. A recent finding that some of the cell cycle defects of E2f3À/À MEFs can be rescued by perturbations in the Arf/p53 pathway suggest that low levels of E2F may act, at least in part, through the activation of checkpoint pathways (Aslanian et al., 2004) . Another, alternative possibility is that E2F and RB directly regulate DNA replication in a transcriptionindependent manner (see below). At the moment, the most likely scenario is that multiple E2F-dependent activities contribute to the regulation of cell cycle progression.
Despite being heralded as a critical regulator of cell cycle progression, E2F activity does not seem to be as essential in vivo as one might have expected. In Drosophila, flies mutant for E2F or DP genes reach late stages of development (Frolov et al., 2001; Royzman et al., 1997) . Similarly, in mice, DP1 (which is the predominant DP protein) and pRB are required in extraembryonic cells, but are largely dispensable for the development of the embryo proper (Wu et al., 2003; Kohn et al., 2004) . These observations are highly reminiscent of in vivo studies of other cell cycle regulators, such as cyclins E1 and E2, cdk2 and the Dtype cyclins, that show tremendous resilience of the cell cycle to perturbation during animal development (Berthet et al., 2003; Geng et al., 2003; Ortega et Perhaps, E2F can be viewed as an important switch that can be engaged to drive or prevent cell proliferation depending on the context. Clearly, there are multiple ways of regulating cell cycle progression, and E2F is just one of them. Hence, locking E2F in a constitutively active or repressed state has a more potent effect on cell proliferation than removing this type of control.
Direct regulation of DNA replication?
Several lines of evidence suggest that E2F and RB proteins connect directly to the process of DNA replication. RB has been shown to bind to several DNA replication proteins in both mammals and in flies (Takemura et al., 1997; Sterner et al., 1998; Royzman et al., 1999; Bosco et al., 2001; Pennaneach et al., 2001; Gladden and Diehl, 2003; Angus et al., 2004) . In mammalian cells, RB and E2F have been localized to sites of DNA replication early in S phase Lai et al., 2001) , although this association remains controversial (Dimitrova and Berezney, 2002; Angus et al., 2004) . pRB was also found to be recruited to certain replication initiation sites after DNA damage, presumably to suppress abnormal replication activity (Avni et al., 2003) . In Drosophila, dE2F1 and RBF1 associate with Orc proteins and are bound in vivo near replication origins that control chorion gene amplification in follicle cells during oogenesis (Bosco et al., 2001) . It has been suggested that dE2Fs and RBFs control both the shut off of genomic DNA synthesis and origin function in these cells (Bosco et al., 2001; Cayirlioglu et al., 2001) in a manner that is independent of transcription. A recent study in mammalian cells proposed that pRB inhibits DNA replication in part by disrupting the chromatin association of PCNA (Angus et al., 2004) .
Currently, it is uncertain whether E2F and RB directly regulate DNA replication during the normal cell cycle progression of most cells, or whether their functions are restricted only to certain situations, such as in response to DNA damage or in specific developmental settings. This issue has been problematical because of the difficulty of distinguishing between direct and indirect effects of E2F and RB on cell cycle progression. As E2F and RB family members have so many potential protein partners, it is also unclear as to how they might affect DNA replication. E2F and RB proteins may interact directly with components of the replication machinery, as proposed, but they may also affect replication by recruiting complexes that alter chromatin structure. Alternatively, E2F/RB complexes may recruit proteins that can modify and alter the activities of nearby replication factors.
Regulation of mitosis
The idea that E2F regulates proliferation at multiple points in the cell cycle was underscored by the finding that many putative E2F target genes have functions required for mitosis (reviewed in DeGregori, 2002; . These include genes with functions in centrosome duplication, spindle checkpoints, chromosome condensation and segregation, cytokinesis and centromeric proteins. Misexpression of some of these genes is known to lead to defects in mitosis and to contribute to genomic instability. For instance, Mad2, a known E2F target gene, is misexpressed in cells with deregulated E2F activity and this leads to mitotic defects and aneuploidy (Hernando et al., 2004) . Several of these targets are thought to be expressed at times in the cell cycle that are later than the G1/S transition. Currently, it is unclear how the expression of mitotic genes might be delayed in the cell cycle relative to the S-phase E2F targets. Most likely, the expression of these genes is the result of the combined actions of E2F and other transcription factors, and that synergistic events occur in a stepwise manner. However, the underlying mechanism is yet to be described.
Studies in both mammalian cells and in worms point to a role for E2F in the inhibition of the anaphasepromoting complex, and this may be another means by which E2F influences cell cycle progression (Lukas et al., 1999; Fay et al., 2002; Garbe et al., 2004) . Saavedra and colleagues reported that inactivation of E2F3 leads to centrosome amplification, mitotic spindle defects and aneuploidy, and suggested that E2F3 functions to coordinate the DNA replication with the centrosome duplication cycle . Work in Drosophila suggests that E2F is an important determinant of the length of time that cells spend in different phases of the cell cycle. Reis and Edgar proposed that E2F proteins, by acting on both the G1/S and G2/M transitions, enable cells to maintain normal proliferation rates by altering the length of G2 in response to alterations in the length of G1 (Reis and Edgar, 2004) . Perhaps, the clearest evidence that E2F is generally required for cell cycle progression, rather than acting solely at the G1/S transition, comes from the phenotype observed in MEFs when all three activator E2Fs were inactivated. E2f1À/À; E2f2À/À; E2f3À/À cells do not arrest in G1 but appear to be blocked at all phases of the cell cycle , suggesting that E2F is needed to drive cells through multiple cell cycle transitions.
In summary, directly or indirectly, E2F activity has an impact on multiple events that are required for the proper duplication and segregation of the genetic material.
A role for E2F in DNA repair and DNA damage checkpoint control A surprisingly large number of genes with functions in DNA repair and recombination and DNA damage checkpoints were identified in the expression and promoter-binding screens for E2F targets (Ishida et al., 2001; Muller et al., 2001; Ren et al., 2002; Dimova et al., 2003) . Indeed, there are now a fairly extensive series of links between the E2F/RB pathway and DNA replication, recombination and repair.
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Several studies have suggested a functional role for E2F1 in the DNA damage response. E2F1 protein levels increase in cells treated with DNA-damaging agents (Huang et al., 1997; Lin et al., 2001; Stevens and La Thangue, 2004 and references therein; Stevens et al., 2003) . The induction of E2F1 is thought to be due, primarily, to an increase in stability of the protein. One study reports that E2F1 stabilization is due to phosphorylation at Ser 31 by the ataxia-telangiectasiamutated (ATM) and ataxia-telangiectasia and Rad3-related (ATR) checkpoint kinases (Lin et al., 2001) , while another suggests that the checkpoint kinase 2 (Chk2) phosphorylates E2F1 at Ser 364 upon DNA damage (Stevens et al., 2003) . It is not clear whether the two kinases cooperate and whether in addition to stabilizing the protein these phosphorylation events regulate other activities of E2F1.
What are the consequences of DNA damage-induced E2F1 activity? In response to DNA damage, a cell can either undergo programmed cell death or trigger a damage checkpoint -allowing it to arrest the cell cycle while repairing its DNA. Damage-induced E2F1 activity can result in apoptosis (Huang et al., 1997; Lin et al., 2001; Stevens et al., 2003) , and E2F1 is required for DNA damage-induced cell death in mouse thymocytes (Lin et al., 2001) . Some studies also suggest a role for E2F1 in checkpoint control. Liu and colleagues report that upon DNA damage and ATM phosphorylation, the transcriptional activity, the apoptotic and the Sphase-inducing activities of E2F1 are inhibited by binding to TopBP1, and that this inhibition was RB independent (Liu et al., 2003) . Furthermore, TopBP1 recruited E2F1 to BRCA1-containing nuclear foci. Interestingly, E2F1 has also been implicated in the recruitment of the Mre11 recombination/repair complex to origins of DNA replication (Maser et al., 2001) . These findings suggest a direct role for E2F1 in DNA damage checkpoints and/or repair. Additionally, increased E2F1 activity could lead to an increase in the transcript levels of genes encoding recombination, repair and checkpoint proteins such as chk1, fen1 and BRCA1, as suggested by expression-and promoter-binding studies. These numerous links raise the intriguing possibility that the cellular response to DNA damage is determined, at least in part by the strength of E2F activity present in cells, and by the modulation of this activity in response to DNA damage.
Regulation of apoptosis
Studies in mammalian cells show that E2Fs can promote cell death when overexpressed or when activated in response to DNA damage. Similarly, experiments in flies have shown that the ectopic expression of dE2F1 also induces apoptosis (Asano et al., 1996; Du et al., 1996b) . Some workers report that induction of cell death is a unique property of E2F1 (DeGregori et al., 1997; Kowalik et al., 1998; Lissy et al., 2000; Leone et al., 2001) , others have shown that E2F2 and E2F3 also possess this ability (Dirks et al., 1998; Vigo et al., 1999; Ziebold et al., 2001 ).
The mechanisms of E2F-mediated cell death remain uncertain. Multiple ways by which E2F can induce apoptosis have been proposed and a large set of apoptotic targets have been identified. There is no systematic set of rules that govern E2Fs effects on the apoptotic response, and we will briefly discuss below the multiple roads that can lead from E2F to cell death.
In both animal models and tissue culture studies, E2F can induce apoptosis in a p53-dependent as well as a p53-independent manner (reviewed in Trimarchi and Lees, 2002; Bell and Ryan, 2004) . Several mechanisms for p53-dependent apoptosis have been proposed. E2F can affect p53 stability through the regulation of the p14(p19)/Arf tumor suppressor gene, which is a known E2F target gene (DeGregori et al., 1997; Bates et al., 1998; Parisi et al., 2002; Aslanian et al., 2004) . However, studies in both mice and in human fibroblasts indicate that E2F can induce p53-dependent apoptosis in the absence of Arf (Tolbert et al., 2002; Tsai et al., 2002; Lindstrom and Wiman, 2003) , suggesting the existence of alternate mechanisms for p53 induction. One study suggests that the cyclin A-binding domain of E2F1 directly interacts with, and stabilizes, p53 in response to DNA damage (Hsieh et al., 2002) , while another demonstrated that E2F1 induces p53 phosphorylation and stabilization in the absence of p19/Arf (Rogoff et al., 2002) . These effects on p53 are believed to be transcription independent, as the transactivation domain of E2F1 was dispensable for p53 induction (Nip et al., 2001) .
Two distinct pathways have been proposed for the induction of p53-independent apoptosis by E2F. In cells lacking p53, the p53 family member, p73, has been shown to play a role in E2F-induced cell death Lissy et al., 2000; Stiewe and Putzer, 2000) . Another mechanism is via the inhibition of antiapoptotic signaling, specifically the tumor-necrosis factor receptor-associated survival response (Phillips et al., 1999) .
The mechanisms of E2F-induced apoptosis differ not only in the type of target for E2F but also in the means by which E2F is thought to function. While the regulation of p19/Arf and p73 is thought to be at the level of transcription, several studies report that the transactivation function of E2F1 is dispensable for the induction of apoptosis in some situations (Phillips et al., 1999; Nip et al., 2001; Hsieh et al., 2002; Stanelle et al., 2003) . Others propose that there are additional E2F transcriptional targets with proapoptotic functions. E2F is thought to downregulate the expression of Mcl-1, an antiapoptotic member of the Bcl-2 family (Elliott et al., 2001; Croxton et al., 2002) , and induce expression of proapoptotic genes such as PUMA, Noxa, Bim, SIVA and several members of the caspase family Nahle et al., 2002; Cao et al., 2004; Fortin et al., 2004; Hershko and Ginsberg, 2004; Young and Longmore, 2004) . For some of these promoters, direct regulation by E2F has been demonstrated, but it is not clear whether and how their expression contributes to E2F-mediated apoptosis. Furthermore, some of these target genes may be regulated differentially in response The E2F family of transcription factors DK Dimova and NJ Dyson to different signals. An example of such differential regulation is the expression of Apaf-1, which is induced and its promoter is bound by E2F upon E2F1 overexpression Furukawa et al., 2002) . However, in response to DNA damage, E2F1 seemed to play no role in the regulation of Apaf-1 expression and E2F1 was not found at the promoter (Pediconi et al., 2003) . How is E2Fs apoptotic function regulated, and why does not the elevated E2F activity that occurs naturally in S phase kill normal cells during cell cycle progression? pRB can block E2F-induced apoptosis and this is likely to provide one level of control (reviewed in Lipinski and Jacks, 1999; Harbour and Dean, 2000b) . The ability of cells to suppress the apoptotic potential of E2F1 during the course of normal cellular proliferation is dependent on the Ras-PI3 kinase-Akt signaling pathway (Hallstrom and , but how this occurs is unclear. E2F activity is modulated following DNA damage (see previous section), and it is possible that similar types of regulation also occur during normal cell cycle progression. This is suggested by the finding that the E2F1-TopBP1 interaction occurs not only after damage but also during the normal G1/S transition (Liu et al., 2004) .
The effects of deregulated E2F activity are pleiotropic and vary in different settings, either promoting cellular proliferation or promoting cell death. Future studies are needed to dissect the context-specific functions of E2F and explain how its dual roles in proliferation and apoptosis are controlled. As the failure in surveillance and apoptotic mechanisms is known to give rise to tumors, and because mutations in the RB pathway that ultimately lead to deregulated E2F activity are so frequent in human cancer, this issue is an especially important aspect of E2F research.
A role for E2F in differentiation and development
The analysis of animals specifically lacking members of the E2F and RB families has focused attention on their roles during normal development. Mutant phenotypes have been described in mice, flies, worms and frogs (for an extensive review see Classon and Dyson, 2001; Classon and Harlow, 2002; DeGregori, 2002; Trimarchi and Lees, 2002) . E2F knockout mice display various physiological and developmental defects. The disruption of E2f1 results in decreased T-cell apoptosis and testicular atrophy, and surprisingly in the development of a broad spectrum of tumors (Field et al., 1996; Yamasaki et al., 1996) . E2f2 mutant mice also exhibit increased tumorigenesis, as well as increased proliferation of hematopoietic cells and autoimmunity (Murga et al., 2001; Zhu et al., 2001) . E2f3À/À mice display partially penetrant embryonic lethality and heart defects (Humbert et al., 2000b) . E2f4À/À mice are runted and have hematopoietic, craniofacial and intestinal defects (Humbert et al., 2000a; Rempel et al., 2000) . Mice lacking E2F5 develop hydrocephalus and are perinatal lethal (Lindeman et al., 1998) . Dp1 null mice exhibit early embryonic lethality due to failure of extraembryonic development (Kohn et al., 2003, 2004 ). The molecular events that are responsible for these defects have been difficult to pin down. The difficulties involved have been illustrated by the discovery that the embryonic lethality of RbÀ/À and Dp1À/À mice is due to defects in extraembryonic development (Kohn et al., 2003 (Kohn et al., , 2004 Wu et al., 2003) . The finding that E2f3 mutants also exhibit placental defects (G Leone, personal communication) points to an essential role for these proteins in the development of the extraembryonic lineages.
The idea that E2F/RB proteins are important during development is further supported by studies in flies, worms and frogs. In C. elegans E2F is required for embryonic asymmetry (Page et al., 2001) , and E2F and RB antagonize Ras signaling during vulval development (Ceol and Horvitz, 2001 ). In Drosophila, E2F is required for the establishment of the dorsoventral polarity in the oocyte (Myster et al., 2000; Cayirlioglu et al., 2001) , whereas in Xenopus, E2F is required for ventral and posterior cell fate determination during early embryogenesis (Suzuki and Hemmati-Brivanlou, 2000) .
E2Fs roles in differentiation are, perhaps, the most mysterious aspect of E2F function. A role for repressive E2F/pocket-protein complexes is suggested by the finding that mice lacking E2F4, E2F5, or p107 and p130 exhibit developmental defects that result from defective differentiation of various cell lineages (Cobrinik et al., 1996; Lindeman et al., 1998; Rempel et al., 2000; Humbert et al., 2000a) . Studies with cultured cells indicate that E2Fs and pocket proteins can have distinct and often opposing effects on differentiation. Cells lacking p107 and p130 differentiate with high efficiency, whereas pRB-deficient cells exhibit differentiation defects in adipocyte differentiation assays . Inhibition of E2F1 activity is necessary for differentiation in several settings (Paramio et al., 2000; Porse et al., 2001; Scheijen et al., 2003; Wong et al., 2003) , but impairs adipogenesis (Fajas et al., 2002) . Overexpression of E2F4 is sufficient to trigger the differentiation of neuronal precursors (Persengiev et al., 1999) and increases the differentiation rate of human keratinocytes (Paramio et al., 2000) , but loss of E2F4 stimulates adipogenesis (Fajas et al., 2002; Landsberg et al., 2003) . The conclusion that can be drawn from these findings is that the role of E2Fs in differentiation is context specific and differs between E2F family members and between cell types.
What is the role of E2F/RB complexes in differentiation? One possibility is that they are simply required to establish a cell cycle arrest that is permissive for differentiation. However, several findings suggest that they play a more direct role in this process. For instance, adipogenic factors such as C/EBPa and PPARg can interact with E2F and elicit different biological responses (Altiok et al., 1997; Slomiany et al., 2000; Porse et al., 2001) . E2F proteins can also induce the expression of genes required for differentiation in mammals , and directly repress differentiation markers in flies . Furthermore, the opposing effects of E2F1 and E2F4 on adipocyte differentiation have been linked to their ability to induce PPARg transcription during clonal expansion and to repress its expression during terminal differentiation, respectively (Fajas et al., 2002) . Collectively, these observations suggest that E2Fs can directly regulate differentiation and this activity of E2F warrants further investigation.
The results of studies of the role of E2F and RB in normal development and differentiation have highlighted our limited understanding of the in vivo functions of these proteins and the gulf that remains between molecular studies of E2F-dependent transcription and in vivo studies of E2F function. One of the major goals of ongoing studies is to identify the cells that are the root cause of the developmental defects and to determine the changes in E2F-dependent transcription that occur in these cell types.
Mechanisms of transcriptional activation and repression by E2F
The complexity of the mammalian E2F transcriptional network, both in terms of number of transcriptional complexes as well as number of putative target genes, has made the study of the method of E2F action less than straightforward. The mechanisms of transcriptional activation and repression by E2F and RB have been investigated extensively. The main conclusion to emerge from these studies is that E2F-dependent transcription is accompanied by dynamic changes in histone modifications. Activator E2Fs have been shown to interact with various histone acetyltransferases (HAT), whereas RB is believed to recruit components of different chromatin-modifying complexes with histone deacetylase activities (HDAC), histone methyltransferase activities, DNA methyltransferase activities and ATP-dependent chromatin remodeling activities (for a review see Harbour and Dean, 2000a; Ferreira et al., 2001; Frolov and Dyson, 2004) . In general, however, attempts to identify essential components of the activation and repression machinery have met with very limited success.
Why has it been so difficult to determine how E2F activates and RB family members repress transcription? One reason may be that many studies have focused on mechanisms of repression used by pRB at 'classic' E2F target genes. The problem here is that it is far from certain that pRB is directly required for the regulation of these targets for much of the time. Many cell cycle-regulated E2F targets are derepressed in p107À/À;p130À/À but show little or no changes in RbÀ/À cells (Herrera et al., 1996; Hurford et al., 1997; Mulligan et al., 1998) . Several studies have failed to detect pRB at these promoters, whereas p107 and p130 are readily detectable (Takahashi et al., 2000; Wells et al., 2000; Aslanian et al., 2004) . Indeed, the analysis of RbÀ/À cells revealed that pRB is not required for HDAC recruitment to several of the traditional E2F targets . Thus, either pRB does not regulate these promoters directly or it may be recruited there only under specific circumstances, as has been proposed (Dahiya et al., 2001; Narita et al., 2003) . It is uncertain whether all pocket proteins use the same mechanisms of repression and it may not be accurate to extend conclusions drawn from studies of one family member to the others.
The second issue is that much of the data is correlative. This is true even where histone modifications have been monitored in vivo. It is often uncertain whether changes in histone modification precede the action of E2F and RB, whether they are the direct result of this action, or whether they are an indirect consequence to changes in transcription. Finally, the large number of putative corepressors and coactivators raises the possibilities that (a) there are multiple, redundant mechanisms of action, and that (b) the roles of specific cofactors will vary from promoter to promoter.
Until recently, most of the work on E2F has employed overexpression approaches and reporter constructs and it has been difficult to assess the roles of endogenous corepressor complexes in transcriptional control. However, the use of mutant cells and RNAi techniques has begun to provide evidence about the mechanisms of repression that are required at some E2F-regulated promoters. It is clear that histone acetylation and deacetylation play a role in the regulation of many E2F targets transcribed at G1/S (reviewed in Frolov and Dyson, 2004) . For instance, HDAC1 is not recruited to several promoters in p107À/À, p130À/À cells, and recent work provides strong evidence that the recruitment of the Tip60 HAT complex and histone acetylation is a consequence of E2F binding (Taubert et al., 2004) . However, studies with HDAC inhibitors indicate that not all E2F-regulated genes are sensitive to deacetylation, suggesting that other mechanisms may also contribute to transcriptional silencing (Luo et al., 1998; Siddiqui et al., 2003; Taylor-Harding et al., 2004) . The elevated expression of E2F target genes, such as cycA, cycE and cycD1 in cells lacking Suv39h, supports the idea that histone methylation is an important mechanism of repression (Nielsen et al., 2001; Ait-Si-Ali et al., 2004) . Interestingly, Ait-SiAli and colleagues report that histone methylation is not required for silencing of S-phase genes in cycling cells but is important in differentiated cells (Ait-Si-Ali et al., 2004) . Differences in histone methylation of E2F targets were also observed between senescent and quiescent cells (Narita et al., 2003) . These findings strongly suggest that the type of repression varies depending on the cellular state.
A novel RBF-associated complex comprised of p55/ CAF1 and other Myb-interacting proteins, the dREAM complex, was recently shown to be functionally required for the repression of a subset of E2F target genes in flies Korenjak et al., 2004) . Parallels between studies in Drosophila and C. elegans suggest that this is an evolutionary conserved mechanism of control. This complex appears to be required for the silencing of E2F targets that are developmentally regulated and encode differentiation markers. A recent The E2F family of transcription factors DK Dimova and NJ Dyson study using RNAi to knock down putative corepressors in Drosophila cells found that most of the corepressors assayed, including components of dREAM complex, were not required for RBF-mediated repression of G1/ S-regulated E2F targets genes in cycling cells (TaylorHarding et al., 2004) . Despite the increasing complexity, these recent findings suggest some general conclusions. First, different types of E2F target genes have different requirements for corepressor proteins, and it is the type of E2F regulation that determines the mechanism of repression. Secondly, distinct types of transcriptional repression are likely to operate at different promoters, even within the same category of E2F targets, and are likely to act at the same promoter in different cellular states. Finally, there is likely to be considerable redundancy between different corepressor complexes.
The functional integration of individual E2F complexes
In our opinion, the key to understanding the diverse biological functions of E2F family members lies in understanding how this network of genes operates over its full range of targets. Which E2F proteins are important, at which promoters, and when? And what are the rules that govern how these activities are integrated? Understanding the functional integration of individual components of the network is complicated by the number of E2F/RB complexes as well as by their interdependency. The large number of potential E2F targets revealed by microarray studies illustrates the scale of the problem.
E2F family member-specific functions
The variety of E2F complexes present in mammalian cells suggests a complexity of function in which individual components have evolved to perform distinct tasks. This idea is supported by the differences in transcriptional regulation, post-translational modifications, and interactions with other proteins that have been observed for the different family members. This suggestion is reinforced by the unique phenotypes of knockout animals (reviewed in Helin, 1998; Muller and Helin, 2000; Classon and Dyson, 2001; DeGregori, 2002; Trimarchi and Lees, 2002) . The roles of individual family members may be determined by both the subset of E2F targets that they control and the signaling pathways that they respond to.
Unique functions for E2Fs at traditional cell cycleregulated target genes? The idea that E2F and RB family members have specialized functions is a recurrent theme in the E2F literature (see for examples DeGregori, 2002 and references therein; Herrera et al., 1996; DeGregori et al., 1997; Hurford et al., 1997; Mulligan et al., 1998; Vigo et al., 1999; Muller et al., 2001; Giangrande et al., 2004) . Several studies have shown that the overexpression of different E2F family members gives qualitative differences in the activation of target genes (see for examples DeGregori et al., 1997; Vigo et al., 1999) . However, attempts to distinguish the DNA-binding specificities of individual E2Fs have been largely unsuccessful and most ChIP experiments have shown that the promoters of many cell cycle-dependent E2F-responsive promoters bind multiple E2F family members (Takahashi et al., 2000; Wells et al., 2000; Rayman et al., 2002) . Thus, the functional importance of individual E2F and RB proteins at a given promoter may not be determined by selective binding, but rather by the differential ability of individual family members to interact with additional cofactors that are required for transcriptional control.
Recent studies have lent credence to the idea that individual E2F proteins have specific properties at cell cycle-regulated promoters. Schlisio et al. observed a cooperative activation of the Cdc6 promoter by YY1, the YY1-binding protein RYBP and E2F2/E2F3. Their results suggest that the ability of E2F2 and E2F3, but not E2F1, to bind and regulate this promoter is due to their capacity to interact with RYBP (Schlisio et al., 2002) . Giagrande and colleagues show that E2F3 is preferentially used at several cell cycle promoters and suggest that the specificity of binding and regulation is achieved through combinatorial gene control involving the E box family member TFE3 (Giangrande et al., 2003 (Giangrande et al., , 2004 . Together, these studies illustrate how a differential requirement for E2F proteins can be correlated to differences in protein-protein interactions with other transcription factors.
What is the purpose of such a system? One could imagine that a degree of functional overlap and unique function has been built into the activator E2Fs to optimize the timing and levels of gene expression at the G1/S transition and to provide a mechanism to fine-tune the patterns or timing of gene expression in particular circumstances.
Unique functions for E2Fs at nontraditional target genes Most transcriptional studies have been performed using the 'classic' cell cycle-regulated E2F target genes. However, the lists of putative E2F targets contain both positive and negative regulators of cellular proliferation and cell differentiation, genes with proand antiapoptotic functions, genes with tissue-specific expression patterns (DeGregori, 2002 and references therein; Ishida et al., 2001; Muller et al., 2001; Ren et al., 2002; Dimova et al., 2003; Young et al., 2003) . Given that E2F-responsive genes can be subdivided into a variety of functionally related groups, it is easy to imagine that the expression of E2F-regulated genes may be tailored in different cellular situations to favor distinct subsets of targets. This would be simple to accomplish if different family members are rate limiting for the expression of distinct sets of genes. Work from several groups indicates that this scenario is likely to be true: that individual E2F and RB family members have unique functions at some promoters.
Several studies have identified promoter sequences that are selectively bound by individual E2F and RB family members. Expression studies using E2f1À/À mice lead to the discovery of several genes whose promoters were bound only by E2F1 and appear to be specifically regulated by E2F1 but not other E2Fs (Wells et al., 2002) . Similarly, Drosophila studies revealed a group of genes that were exclusively dependent on the repressor E2F, dE2F2 and were not bound by dE2F1, the activator E2F . Intriguingly, in both species, the newly identified targets do not encode proteins with cell cycle functions. Another recently described example is the promoter for the Arf tumor suppressor, which was found to be repressed by E2F3b. Interestingly, E2F3 was the only E2F protein bound to the Arf promoter under normal growth conditions (Aslanian et al., 2004) . The finding that these promoters were not bound by other E2Fs even in the absence of E2F1, dE2F2 or E2F3 (Wells et al., 2002; Dimova et al., 2003; Aslanian et al., 2004) illustrates the specificity of the regulation. Other examples include the promoter of the Mad3 transcription factor that is exclusively regulated by E2F1 (Fox and Wright, 2003) , a novel E2F4-regulated promoter (Wells et al., 2003) , and the unique ability of p107 to repress c-myc expression (Chen et al., 2002) .
The discovery of promoters that are selectively bound by individual family members is a significant step towards understanding the molecular mechanisms behind the biological functions of E2F and RB proteins, and it will be important to expand these analyses to determine the contributions of each family member over the full range of E2F-regulated genes. It is not clear how binding and target specificity is achieved. As described above, it is likely that the specific recruitment of E2F/ RB proteins is influenced by selective interactions with other factors, and/or by selective responses to cellular events (see below).
Transcriptional responses to distinct signals
Selective recruitment of E2F and RB proteins Another recent development is the idea that E2Fs are not only tailored for specific targets, but that they can also be recruited to those targets in response to an appropriate signal. Dynamic changes in the binding of E2Fs have been observed at promoters of both cell cycle-regulated and apoptotic genes by several groups, and these studies suggest that DNA damage signals affect the type of target genes selected by E2Fs. E2F4 is recruited to the promoters of mitotic regulators in G2 after doxorubicin treatment and the increased binding of E2F is required for sustained G2 arrest in response to genotoxic stress (Polager and Ginsberg, 2003) . E2F1 is recruited to the Mcm10 and TopBP1 promoters following serum stimulation, but is displaced after UV irradiation, whereas E2F4 displayed the opposite binding pattern (Yoshida and Inoue, 2004) . In another study, E2F4 was recruited to the cell cycle-regulated DHFR promoter upon DNA damage, while E2F1 was specifically recruited to the promoter of the apoptosis regulator p73 (Pediconi et al., 2003) . Furthermore, changes in expression and binding of E2F differed not only between promoters but also in response to the type of damage induced, indicating that different DNA-damaging agents elicit distinct regulatory signals (Pediconi et al., 2003; Yoshida and Inoue, 2004) .
Selective recruitment of E2F has also been observed in response to oncogenic stress. For instance, E2F1 is bound to the caspase-7 promoter in cells expressing the E1A viral oncogene (Nahle et al., 2002) . Similarly, E2F1 is recruited to the Arf promoter only in response to various oncogenic stimuli (Aslanian et al., 2004; PJ Iaquinta and JA Lees, personal communication) . At the Apaf1 promoter, expression is induced and E2F bound only when E2F1 activity is elevated Furukawa et al., 2002) . These responses are not unique to E2Fs. It has been proposed that pRB is recruited to cell cycle promoters only during senescence (Dahiya et al., 2001; Narita et al., 2003) , and p107 containing complexes are specifically recruited to the c-myc promoter upon TGFb signaling (Chen et al., 2002) .
CDK-independent regulation of E2F/RB repressor complexes In addition to selective recruitment of E2F complexes, the disruption of E2F/RB repressor complexes can also be affected by particular signals. It has long been known that the phosphorylation of pocket proteins by G1 Cdk activity can disrupt E2F/RB repressor complexes. Accumulating evidence also points to Cdk-independent functions of E2F and RB family members. For instance, E2F4/p107 and E2F5/p107 complexes were found to be recruited by TGFb to the c-myc promoter irrespective of cell cycle phase, indicating that these complexes were stable even in the presence of high Cdk activity (Chen et al., 2002) . Wells and colleagues identified human promoters, which were bound by E2F1 and pRB in S phase (Wells et al., 2003) . In flies, the repressor E2F/RB complexes are displaced from the promoters of G1/S-regulated transcripts, but remain intact at the promoters of differentiation genes in S phase . These complexes are not disrupted by cell cycle progression, but presumably do respond to signals in the tissues where genes expression occurs. An additional example of this comes from Young and colleagues who observed that, in human cells, p107 and p130 were displaced from the promoters of cell cycle-regulated genes during in S phase, but remained bound at the promoters of apoptotic regulators (Young and Longmore, 2004) . These results suggest that signals other than G1 Cdks control the stability of repressor complexes at some promoters, but in most cases the precise nature of these regulatory signals is unknown.
Another demonstration of unusual E2F/RB regulation comes from studies in mouse liver. C/EBPa can disrupt S-phase-specific E2F/p107 complexes in the liver of newborn mice (Timchenko et al., 1999a) , and this ability of C/EBPa can also be observed in cultured adipocytes (Timchenko et al., 1999b) . E2F4/RB complexes at the c-myc promoter were found to be disrupted following partial hepatectomy in the liver of young animals, whereas in old animals, a complex containing C/EBPa, E2F4 and pRB remains stable and is not disrupted (Iakova et al., 2003) . p38MAPK has also been shown to affect the stability of E2F/RB complexes (Kishore et al., 2003; Nath et al., 2003) . Upon apoptotic stimulation by Fas, pRB is inactivated by p38 independent of Cdks, suggesting that mitogenic and apoptotic stimuli can inactivate pRB by different means (Nath et al., 2003) .
These observations indicate that E2F complexes can respond to a variety of signals and can function in a Cdk-independent manner. One of the obvious implications is that the level of Cdk activity may not always equate to the level of pRB or E2F function.
In summary, the E2F transcriptional network possesses a far greater flexibility that initially suspected. The unique functions of individual E2Fs, their ability to respond to different signals and their potential for celland tissue-specific effects collectively create a plasticity in this regulatory network. Tissue-specific binding of E2F proteins to promoter elements has been observed in both the mouse and flies (Wells et al., 2002; Dimova and Dyson, unpublished observations) , and the transcriptional outputs from a single E2F may differ between cell and/or tissue types. Such plasticity could explain why E2F and RB family members affect the expression of such a diverse collection of genes and it may potentially provide molecular explanations for the unexpected phenotypes observed in mutant animals.
A role for E2F in tumorigenesis
Mutations in the RB pathway (Figure 2b ) are believed to occur in nearly all human cancers (Sherr, 1996) . Most frequent are mutations in upstream regulators such as the Cdk inhibitor p16 INK4A and cyclin D1. RB1, which was the first tumor suppressor gene to be cloned, was initially identified as the genetic lesion associated with the development of retinoblastoma (Knudson, 1971; Friend et al., 1986) . Subsequently, mutations in RB1 were also identified in some adult sporadic cancers (reviewed in Weinberg, 1992) . One of the most compelling reasons for studying the functions of E2F has been the idea that it might explain the significance of the RB pathway in oncogenesis. Such a role was first suggested by the identification of E2F as one of the cellular targets for viral oncoproteins (reviewed in Trimarchi and Lees, 2002) .
The idea that E2F activity is important for tumor development has been buttressed by two lines of investigation. Numerous groups have found deregulated E2F activity in different human cancers, often correlating with poor prognosis (see for examples Nevins, 2001; Gorgoulis et al., 2002; Ebihara et al., 2004; Foster et al., 2004) . Recently, two studies have reported the amplification and overexpression of E2f3 in human bladder cancer, a finding that strongly suggests that deregulated E2F activity can have a causative role in human tumors Oeggerli et al., 2004) .
Further support comes from studies of mice carrying mutant alleles of RB and E2F family members (reviewed in Lipinski and Jacks, 1999; Nevins, 2001; Classon and Dyson, 2001; Classon and Harlow, 2002; DeGregori, 2002; Cam and Dynlacht, 2003) . Mice heterozygous for Rb develop pituitary and thyroid tumors, but do not develop retinoblastoma (Hu et al., 1994; Williams et al., 1994) . However, this tumor phenotype can be modified by mutations in other E2F/RB family members. Mutation of p107 or p130 expands the tumor spectrum, allowing Rb heterozygotes to develop retinoblastomas (Robanus-Maandag et al., 1998; Chen et al., 2004; MacPherson et al., 2004) . Conversely, E2f1, E2f3 or E2f4 mutations partially suppress tumorigenesis in RB mutant mice (Yamasaki et al., 1998; Lee et al., 2002; Ziebold et al., 2003) . Paradoxically, E2f1 À/À and E2f1À/À;E2f2À/À mice are tumor prone (Yamasaki et al., 1996; Zhu et al., 2001) , and the overexpression of E2F1 in transgenic mouse models can both promote and suppress tumorigenesis (Pierce et al., 1998a (Pierce et al., , b, 1999 Conner et al., 2000) . The idea that E2Fs can act as both oncogenes and tumor suppressors was nicely illustrated in a recent study showing that mutation of E2f3 suppressed pituitary tumor formation, while increasing the metastasis of thyroid carcinomas in Rb þ /À animals (Ziebold et al., 2003) . Why E2Fs act as both oncogenes and tumor suppressors is unknown and many theories have been advanced on the subject (reviewed in Macleod, 1999; Yamasaki, 1999; DeGregori, 2002; Trimarchi and Lees, 2002) . One possible explanation is that this stems from their ability to promote both Sphase entry and sensitivity to apoptosis. In addition, E2F1 and E2F2 can also function as negative regulators of cell cycle progression (Murga et al., 2001; Zhu et al., 2001) . The ability of E2Fs to affect the expression of diverse collections of genes and to alter multiple biological processes, rather than just cellular proliferation and apoptosis, may also contribute to their roles as tumor suppressors and oncogenes.
One of the main themes to emerge from the analysis of these mutant animals is the idea that the roles of E2F proteins in tumor suppression and oncogenesis are context specific. The goal for the future is to determine how E2F activities change in different environments, and to understand how E2F functions within the framework of other regulatory pathways. Unfortunately, there is no guarantee that the contexts that are important in the mouse reflect a similar role in the equivalent human tissue. Indeed, the example provided by Rb heterozygosity, which predisposes to different types of tumors in mice and humans, suggests that there will often be differences.
Conclusions and perspective
New findings in recent years have greatly altered our notions regarding the molecular and in vivo functions of the E2F/RB network. These include the discovery of new family members with unusual properties and largely unexplored biological functions; unexpected phenotypes of mutant animals; a diverse collection of biological The E2F family of transcription factors DK Dimova and NJ Dyson activities; an explosion of new putative target genes; and new modes of transcriptional regulation. It is difficult to tie all of these observations in one unifying model of E2F function and many issues await resolution. Nonetheless, several conclusions can be drawn and these in turn yield testable hypotheses that may determine future directions of research.
It is evident that there is not a single E2F-dependent transcriptional program. E2F and RB family members possess target specificity and can regulate distinct sets of genes and in response to different signals. Thus, groups of functionally related genes will be regulated by subsets of E2F/RB proteins in a context-specific manner. What follows is that the E2F/RB pathway should be regarded as a collection of modules with common and distinct activities, which can be used in a variety of ways to accommodate a variety of biological functions. It remains to be determined how many different types of E2F modules exist.
The diverse and sometimes opposing activities of E2F and RB family members, and the fact that they have different modes of regulation, indicate that the biological responses of the pathway vary in different settings.
Hence, any set of data should be viewed only in the context of a particular environment. Studies of E2F/RB function have to take into account the attributes of the particular biological system such as tissue type, extracellular signals, mutations in other signaling pathways, etc. Such considerations may go a long way towards providing molecular explanations for the contextspecific functions of E2F and RB in both normal development and tumorigenesis.
In summary, E2F research has made tremendous progress over the past few years. The major challenge that remains, as always, is to tie the observation of E2F-and RB-dependent phenotypes in vivo to molecular studies of their function. Nonetheless, the outlook is bright, albeit more complicated that we would perhaps have liked.
